BBH.L

BB Healthcare Trust (Red)
Bellevue Healthcare - Net Asset Value(s)
19th December 2024, 10:36
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 7796Q
Bellevue Healthcare Trust PLC
19 December 2024
 

LEI: 213800HQ3J3H9YF2UI82

 

Bellevue Healthcare Trust plc (the 'Company') announces that as at the close of business on 18 December 2024 its unaudited net asset value ('NAV') per ordinary share ('Share') was as follows:

 

NAV per Share (including current financial year revenue items)                                  146.76p

NAV per Share (excluding current financial year revenue items)                                 146.59p

 

Investments in the Company's portfolio have been valued on a bid price basis.

 

Enquiries:

Company Secretary

NSM Funds (UK) Limited                                                                   +44 (0) 20 3697 5770

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVFZMMZGLDGDZM]]>
TwitterFacebookLinkedIn